Self Efficacy: Clinical Trials

2 trials for Self Efficacy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2
Phase 21Unknown 1

Follow Self Efficacy: new trials by email Literature Review of Self Efficacy trials Research Report on Self Efficacy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach for Hip Surgery
QUADRATUS LUMBORUM BLOCK - Self Efficacy
Phase 3UnknownBeni-Suef University52020-11-202020-11-16
Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C
pegylated interferon alpha 2a YPEG-IFN α-2a 180mcg - Self Efficacy, Hepatitis C
Phase 2 / Phase 3UnknownBioGeneric Pharma3002010-11-012011-04-04

Narrower conditions

Hepatitis C (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  RNA Virus Infections (1)  ·  Virus Diseases (1)

Sponsors

Beni-Suef University (1)  ·  BioGeneric Pharma (1)

Countries

Egypt (1)

Top investigators

Gamal Esmat, MD (1)  ·  Mohamed Karim F Ashour, MD (1)